BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argenziano M, Tortora C, Pota E, Di Paola A, Di Martino M, Di Leva C, Di Pinto D, Rossi F. Osteosarcoma in Children: Not Only Chemotherapy. Pharmaceuticals (Basel) 2021;14:923. [PMID: 34577623 DOI: 10.3390/ph14090923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan Q, Yang J, Yao Y, Jia Z, Wang Y, Cheng M, Yan X, Xu Y. Research of the Active Components and Potential Mechanisms of Qingfei Gujin Decoction in the Treatment of Osteosarcoma Based on Network Pharmacology and Molecular Docking Technology. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/7994425] [Reference Citation Analysis]
2 Chen B, Zhao X, Li X, Liu J, Tang J. Fatal heart disease in patients with bone and soft tissue sarcoma. Front Cardiovasc Med 2022;9:951940. [PMID: 36312272 DOI: 10.3389/fcvm.2022.951940] [Reference Citation Analysis]
3 Rossi F, Tortora C, Paoletta M, Marrapodi MM, Argenziano M, Di Paola A, Pota E, Di Pinto D, Di Martino M, Iolascon G. Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives. Cancers 2022;14:4349. [DOI: 10.3390/cancers14184349] [Reference Citation Analysis]
4 Zhao J, Zhao Y, Ma X, Feng H, Jia L. Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients. Sci Rep 2022;12:5029. [PMID: 35322804 DOI: 10.1038/s41598-022-09080-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]